Thrivent Financial for Lutherans
AGIO icon

Thrivent Financial for Lutherans’s Agios Pharmaceuticals AGIO Stock Holding History

Thrivent Financial for Lutherans’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,526
Closed -$583K – 2366
2025
Q2 		$583K Hold
17,526
– – ﹤0.01% 2069
2025
Q1 		$514K Hold
17,526
– – ﹤0.01% 2059
2024
Q4 		$576K Sell
17,526
-7,077
-29% -$332K ﹤0.01% 2192
2024
Q3 		$1.09M Hold
24,603
– – ﹤0.01% 1859
2024
Q2 		$1.06M Sell
24,603
-1,051
-4% -$37.9K ﹤0.01% 1833
2024
Q1 		$750K Hold
25,654
– – ﹤0.01% 2052
2023
Q4 		$572K Sell
25,654
-19,151
-43% -$429K ﹤0.01% 2154
2023
Q3 		$1.11M Buy
44,805
+22
+0% +$582 ﹤0.01% 1672
2023
Q2 		$1.27M Sell
44,783
-2,196
-5% -$54.6K ﹤0.01% 1646
2023
Q1 		$1.08M Hold
46,979
– – ﹤0.01% 1744
2022
Q4 		$1.32M Sell
46,979
-564
-1% -$15.9K ﹤0.01% 1551
2022
Q3 		$1.34M Sell
47,543
-55,776
-54% -$1.5M ﹤0.01% 1483
2022
Q2 		$2.29M Buy
+103,319
New +$2.33M 0.01% 1152
2021
Q1 		– Sell
-350,768
Closed -$15.2M – 2521
2020
Q4 		$15.2M Buy
350,768
+86,829
+33% +$3.43M 0.04% 521
2020
Q3 		$9.24M Sell
263,939
-7,119
-3% -$312K 0.02% 623
2020
Q2 		$14.5M Buy
271,058
+1,387
+0.5% +$64.2K 0.04% 451
2020
Q1 		$9.57M Buy
269,671
+938
+0.3% +$43.3K 0.03% 508
2019
Q4 		$12.8M Buy
268,733
+28,944
+12% +$1.09M 0.04% 507
2019
Q3 		$7.77M Buy
+239,789
New +$9.93M 0.02% 568

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Thrivent Financial for Lutherans's AGIO Position: Q3 2025 in Review

Thrivent Financial for Lutherans sold out of Agios Pharmaceuticals (AGIO) in Q3 2025, closing a stake of 17,526 shares — an estimated $583K sold.

Thrivent Financial for Lutherans first reported a position in AGIO in Q3 2019 and held it in 19 quarters. The position peaked at $15.2M in Q4 2020. 221 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

  • Thrivent Financial for Lutherans reported no remaining Agios Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 17,526 Agios Pharmaceuticals shares in Q3 2025, an estimated $583K.
  • Thrivent Financial for Lutherans first reported a position in Agios Pharmaceuticals in Q3 2019 and held it in 19 quarters.
  • Thrivent Financial for Lutherans's Agios Pharmaceuticals position peaked at $15.2M in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2025, filed 4 Nov 2025.